falsefalse

Lung Cancer TALK: A Review of Data from the IASLC 2020 World Conference on Lung Cancer - Episode 1

WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC

, , ,

Experts in thoracic oncology review data presented at the IASLC 2020 World Conference on Lung Cancer (WCLC) and discuss safety and efficacy of targeted agents for patients with KRAS- or EGFR-mutated non–small cell lung cancer (NSCLC).

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Data from the following clinical trials are discussed:

    • PS0 1.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non–Small Cell Lung Cancer
    • OA04.03 - Mobocertinib in NSCLC With EGFR Exon 20 Insertions: Results From EXCLAIM and Pooled Platinum-Pretreated Patient Populations
    • OA04.04 - Amivantamab in Postplatinum EGFR Exon 20 Insertion Mutant Non–Small Cell Lung Cancer
    x